Colchicine Only Inhibits in Higher Doses Hyperactivated NLRP3 Inflammasome—The Main Respondent for Complications in COVID-19 and Influenza

Despite the enormous theoretical progress, there is currently no effective treatment for the cytokine storm (CS) in COVID-19 and Influenza, which is due to hyperactivation of NOD-like receptor protein 3 inflammasome (NLRP3-I). According to our research, the only way to prevent or interrupt the CS is...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Vanyo Mitev, Georgi Momekov
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	IMR Press 2025-09-01
Rangatū:	Frontiers in Bioscience-Landmark
Ngā marau:	covid-19 influenza nlrp3 inflammasome cytokine storm colchicine doses colchicine toxicity
Urunga tuihono:	https://www.imrpress.com/journal/FBL/30/9/10.31083/FBL44744
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!